Why is Sanofi Consumer Healthcare India Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 10.10% and Operating profit at 5.70% over the last 5 years
2
With ROE of 69.3, it has a Very Expensive valuation with a 25.4 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -17.34%, its profits have fallen by 0% ; the PEG ratio of the company is 2.2
3
Below par performance in long term as well as near term
- Along with generating -17.34% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sanofi Consumer for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sanofi Consumer
-17.34%
-0.56
31.03%
Sensex
-3.52%
-0.26
13.43%
Quality key factors
Factor
Value
Sales Growth (5y)
10.10%
EBIT Growth (5y)
5.70%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.98
Sales to Capital Employed (avg)
2.77
Tax Ratio
25.53%
Dividend Payout Ratio
71.85%
Pledged Shares
0
Institutional Holding
20.46%
ROCE (avg)
-178.66%
ROE (avg)
67.74%
Valuation Key Factors 
Factor
Value
P/E Ratio
37
Industry P/E
37
Price to Book Value
25.37
EV to EBIT
27.57
EV to EBITDA
26.54
EV to Capital Employed
1064.40
EV to Sales
9.86
PEG Ratio
2.22
Dividend Yield
1.77%
ROCE (Latest)
2862.50%
ROE (Latest)
69.27%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Movement
9What is working for the Company
NET SALES(9M)
At Rs 715.90 cr has Grown at 26.89%
PAT(Q)
Highest at Rs 68.80 cr.
EPS(Q)
Highest at Rs 29.91
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Sanofi Consumer
Profit After Tax (PAT) - Quarterly
Highest at Rs 68.80 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Nine Monthly
At Rs 715.90 cr has Grown at 26.89%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 29.91
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Sanofi Consumer
Non Operating Income - Quarterly
Highest at Rs 6.30 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income






